Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ) Short Interest Update

Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ) was the target of a large drop in short interest in the month of February. As of February 28th, there was short interest totalling 3,900 shares, a drop of 41.8% from the February 13th total of 6,700 shares. Based on an average trading volume of 14,700 shares, the days-to-cover ratio is presently 0.3 days. Currently, 0.2% of the company’s stock are sold short.

Invesco Nasdaq Biotechnology ETF Trading Up 0.7 %

IBBQ opened at $22.21 on Friday. Invesco Nasdaq Biotechnology ETF has a 12 month low of $20.14 and a 12 month high of $24.84. The stock has a fifty day moving average price of $22.29 and a 200-day moving average price of $22.94. The firm has a market cap of $39.31 million, a price-to-earnings ratio of 17.68 and a beta of 0.61.

Invesco Nasdaq Biotechnology ETF Dividend Announcement

The company also recently declared a dividend, which was paid on Friday, December 27th. Stockholders of record on Monday, December 23rd were issued a $0.0619 dividend. The ex-dividend date of this dividend was Monday, December 23rd.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently modified their holdings of the company. Tower Research Capital LLC TRC boosted its stake in Invesco Nasdaq Biotechnology ETF by 148.5% in the fourth quarter. Tower Research Capital LLC TRC now owns 28,061 shares of the company’s stock valued at $604,000 after acquiring an additional 16,768 shares in the last quarter. Raymond James Financial Inc. acquired a new stake in shares of Invesco Nasdaq Biotechnology ETF in the 4th quarter worth $888,000. Advisory Services Network LLC grew its stake in Invesco Nasdaq Biotechnology ETF by 5.8% during the 4th quarter. Advisory Services Network LLC now owns 53,609 shares of the company’s stock worth $1,154,000 after buying an additional 2,922 shares during the last quarter. Finally, Strategic Financial Concepts LLC acquired a new position in Invesco Nasdaq Biotechnology ETF during the 4th quarter valued at about $1,699,000.

Invesco Nasdaq Biotechnology ETF Company Profile

The Invesco Nasdaq Biotechnology ETF (IBBQ) is an exchange-traded fund that is based on the NASDAQ / Biotechnology index, a modified market-cap-weighted index of US biotechnology and pharmaceutical companies listed on the NASDAQ. IBBQ was launched on Jun 11, 2021 and is managed by Invesco.